{"disease":{"id":"htlv-i","name":"htlv i"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00340821","title":"A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis","phase":"","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00339807","title":"Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00001156","title":"Assessment of Patients With Multiple Sclerosis (MS)","phase":"","overall_status":"COMPLETED","enrollment_count":1388,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT00001778","title":"Evaluation of Patients With HAM/TSP","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT01754311","title":"Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1","phase":"","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"University Hospital Center of Martinique","has_results":false},{"nct_id":"NCT03226119","title":"MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"MP Biomedicals, LLC","has_results":false},{"nct_id":"NCT03146013","title":"Dual Algorithm Post Market Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"MP Biomedicals, LLC","has_results":false},{"nct_id":"NCT03191526","title":"A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT06616675","title":"Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Hospital Universitário Professor Edgard Santos","has_results":false},{"nct_id":"NCT04301076","title":"Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":30,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04830319","title":"Pilates Method in People With HAM/TSP","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Pedreira, Érika, M.D.","has_results":false},{"nct_id":"NCT03829709","title":"Electromiography Study in the Respiratory Muscle Training in Human Lymphotropic Virus Type 1","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Universidade Metodista de Piracicaba","has_results":false},{"nct_id":"NCT01867320","title":"Raltegravir for HAM/TSP","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT01712659","title":"Ruxolitinib for Adult T-Cell Leukemia","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00272480","title":"Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT05240612","title":"A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":false},{"nct_id":"NCT03075553","title":"Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT02655471","title":"Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Universidad Peruana Cayetano Heredia","has_results":false},{"nct_id":"NCT02631746","title":"Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}